Start Scientific, Inc.
STSC · OTC
12/31/2018 | 9/30/2018 | 6/30/2018 | 3/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.27 | -0.04 | -0.00 | 0.06 |
| FCF Yield | -4.87% | -1.72% | -3.77% | -0.15% |
| EV / EBITDA | -208.80 | -59.33 | -65.66 | -77.80 |
| Quality | ||||
| ROIC | 0.29% | 1.33% | 1.33% | 2.62% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.89 | -0.18 | 0.23 | 0.08 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -183.58% | 54.38% | -2,454.98% | 95.87% |
| Safety | ||||
| Net Debt / EBITDA | -129.89 | -36.52 | -37.99 | -44.51 |
| Interest Coverage | -0.30 | -1.05 | -1.06 | -0.87 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |